EVP Salvadori sold 23,771 ABT shares at $128.50 (Jan 30), reducing stake by 15.9% to 125,697 shares
Salvadori Daniel Gesua Sive, EVP at Abbott Laboratories, executed a sale of 23,771 shares at $128.50 for a total value of $3,054,573.50, reducing his holdings from 149,468 shares to 125,697 shares. The sale occurred near the upper bound of the 52-week range ($100.07–$129.43), with the stock currently trading at $127.93 (30-day and 90-day momentum positive at +13.1% and +7.9%, respectively). The company faces macroeconomic headwinds, with annual revenue declining 8.1% year-over-year despite a substantial market capitalization of $221.9B. Without disclosure of whether this transaction followed a scheduled trading plan, the sale pattern itself—a 15.9% reduction in holdings at a near-peak valuation—warrants monitoring as part of broader insider activity at the company.